Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails

Table 3

The result of the dichotomous variables.

Study	Intervention	TC		TG		HDL-C
		Total effect	No effect	Total effect	No effect	Total effect	No effect
Lin et al. 2000 [22]	XZK + BGLD	39/41	2/41	41/43	2/43	9/10	1/10
	Placebo + BGLD	12/19	7/19	10/22	12/22	2/6	4/6
Chen et al. 2000 [23]	XZK + BGLD	23/25	2/25	21/23	2/23	7/8	1/8
	Placebo + BGLD	11/21	10/21	9/26	17/26	1/7	6/7
Hao 2002 [25]	XZK + BGLD	41/46	5/46	38/44	6/44	27/45	28/45
	DXK + BGLD	21/41	20/41	29/48	19/48	8/41	13/41